SNY - Sanofi ADR - Stock Price & Dividends

Sanofi, a leading healthcare company, is dedicated to improving lives through innovative therapeutic solutions. With a strong presence in the United States, Europe, Canada, and internationally, the company operates through three main segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.

In the Pharmaceuticals segment, Sanofi focuses on developing and marketing specialty care products, including DUPIXENT for atopic dermatitis, as well as treatments for neurology and immunology, rare diseases, oncology, and rare blood disorders. The company also offers medicines for diabetes and cardiovascular diseases, along with established prescription products.

Through its Vaccines segment, Sanofi provides a range of vaccines to protect against various diseases, including poliomyelitis, pertussis, and hib pediatric vaccines, as well as influenza, booster, meningitis, and travel and endemic vaccines. These vaccines include protection against hepatitis A, typhoid, cholera, yellow fever, and rabies.

In the Consumer Healthcare segment, Sanofi offers a variety of over-the-counter (OTC) products, including cough, cold, and flu remedies, allergy medications, and pain relief products. The company also provides physical, mental, and digestive wellness products, as well as skincare solutions for itching, hydration, aging, cracking, and specialty skincare needs like eczema.

Sanofi is committed to advancing healthcare through strategic collaborations and partnerships. The company has agreements with Exscientia to develop novel small-molecule therapies for oncology and immunology, and with ABL Bio, Inc. to develop a treatment for alpha-synucleinopathies. Additionally, Sanofi has partnerships with Blackstone Life Sciences, Seagen Inc., IGM Biosciences, Inc., Skyhawk Therapeutics, Inc, Adagene Inc., Scribe Therapeutics Inc., and Provention Bio, Inc. to develop and commercialize innovative treatments.

With a rich history dating back to 1994, Sanofi was formerly known as Sanofi-Aventis before changing its name in May 2011. Headquartered in Paris, France, the company continues to drive innovation and improve healthcare outcomes worldwide. For more information, visit https://www.sanofi.com.